TLS 
Triyambak Life Sciences

Nurturing Life Sciences

TLS Online

Nurturing Life Sciences

Store
Login

Practice Questions

  1. Home
  2. Free Resources
  3. Practice Questions
  4. 3128
TLS Online TPP Program

#Question id: 3341


In a given population of 400 individuals, 64 percent of population is caused  cancer due to completely dominat allele B. Assuming the population is in Hardy- Weinberg equilibrium, which of the following is the expected proportion of individuals who are not expected to develop the cancer?

#Unit 11. Evolution and Behavior
  1. 19/400

  2. 20/400         

  3. 38/400       

  4. 144/400


Answer:- Option(s): 4


To access the video solutions, Please subscribe TPP program.

Subscribe Now 
More Questions
TLS Online TPP Program

#Question id: 1779

#Unit 4. Cell Communication and Cell Signaling

Complement component C3 is cleaved by:

TLS Online TPP Program

#Question id: 1780

#Unit 4. Cell Communication and Cell Signaling

Induces dissociation and inhibition of C1r2s2 from C1q; serine protease inhibitor

TLS Online TPP Program

#Question id: 1781

#Unit 4. Cell Communication and Cell Signaling

Binds C5b678 on host cells, blocking binding of C9 and the formation of the MAC complex

TLS Online TPP Program

#Question id: 1782

#Unit 4. Cell Communication and Cell Signaling

Function of DAF (CD55)

TLS Online TPP Program

#Question id: 1783

#Unit 4. Cell Communication and Cell Signaling

There are two C3 convertases in the alternative tickover pathway:

TLS Online TPP Program

#Question id: 1784

#Unit 4. Cell Communication and Cell Signaling

which parts are similar among the three pathways

TLS Triyambak Life Sciences Nurturing Life Sciences
TLS Android APP TLS IOS APP

Company

  • About us
  • Careers
  • Terms of service
  • Privacy policy

Help & Support

  • User Guidelines
  • Refund Policy

Products

  • TLS APP
  • TPP APP

Contact Us

117/429-4 Q Block, behind Hotel DNG Grand, Sharda Nagar, Kanpur,
Uttar Pradesh 208025
India
Phone: +91 9919149001, +917007912133
Email: info@triyambak.org

© 2025 Copyright Triyambak Life Sciences Pvt Ltd. All Rights Reserved